Konferenzschrift | Kongress
Inflammatory bowel diseases: microbiota versus the barrier : 14 tables
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783318025361
3318025364
- Maße
-
28 cm
- Umfang
-
S. 268 - 399
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Erschienen in
-
Digestive diseases ; Vol. 31, No. 3/4
- Schlagwort
-
Chronische Darmentzündung
Crohn-Krankheit
Enteritis
Darmentzündung
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel, Freiburg, Br., Paris, London, New York, NY, New Delhi, Bangkok, Beijing, Tokyo, Kuala Lumpur, Singapore, Sydney
- (wer)
-
Karger
- (wann)
-
2013
- Beteiligte Personen und Organisationen
-
Stange, Eduard F.
Dignass, A.
Fellermann, K.
Herrlinger, K.
Falk Symposium (188. : 2013 : Stuttgart)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Stange, Eduard F.
- Dignass, A.
- Fellermann, K.
- Herrlinger, K.
- Falk Symposium (188. : 2013 : Stuttgart)
- Karger
Entstanden
- 2013
Ähnliche Objekte (12)
Inflammatory bowel diseases : microbiota versus the barrier ; Stuttgart, 7. - 8. Juni 2013 ; Falk Symposium 188
Chemokines in Inflammatory Bowel Diseases
Anemia in inflammatory bowel diseases
Histone deacetylases in inflammatory bowel diseases - influence on the antimicrobial barrier
Endoscopic Therapy in Inflammatory Bowel Diseases
Biological therapy for inflammatory bowel diseases
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases
Innate and Adaptive Immunity in Inflammatory Bowel Diseases
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Monogenic causes for early-onset inflammatory bowel diseases
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Inflammatory bowel diseases : microbiota versus the barrier ; Stuttgart, 7. - 8. Juni 2013 ; Falk Symposium 188
Chemokines in Inflammatory Bowel Diseases
Anemia in inflammatory bowel diseases
Histone deacetylases in inflammatory bowel diseases - influence on the antimicrobial barrier
Endoscopic Therapy in Inflammatory Bowel Diseases
Biological therapy for inflammatory bowel diseases
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases
Innate and Adaptive Immunity in Inflammatory Bowel Diseases
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Monogenic causes for early-onset inflammatory bowel diseases
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Inflammatory bowel diseases : microbiota versus the barrier ; Stuttgart, 7. - 8. Juni 2013 ; Falk Symposium 188
Chemokines in Inflammatory Bowel Diseases
Anemia in inflammatory bowel diseases
Histone deacetylases in inflammatory bowel diseases - influence on the antimicrobial barrier
Endoscopic Therapy in Inflammatory Bowel Diseases
Biological therapy for inflammatory bowel diseases
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases
Innate and Adaptive Immunity in Inflammatory Bowel Diseases
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Monogenic causes for early-onset inflammatory bowel diseases